---
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Clinical Study Attribute Terminology
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C142191
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C142191
  :notation: Clinical Study Attribute Terminology
  :definition: A terminology value set relevant to the attributes of the clinical
    study entity.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Primary Clinical Study Sponsor
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C70794
    :notation: Primary Clinical Study Sponsor
    :definition: The individual, organization, group or other legal person taking
      responsibility for securing the arrangements to initiate and/or manage a study
      (including arrangements to ensure that the study design meets appropriate standards
      and to ensure appropriate conduct and reporting). In commercial trials, the
      primary sponsor is normally the main applicant for regulatory authorization
      to begin the study. It may or may not be the main funder. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Primary Clinical Study Sponsor
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Secondary Clinical Study Sponsor
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C70795
    :notation: Secondary Clinical Study Sponsor
    :definition: Additional individuals, organizations or other legal persons, if
      any, that have agreed with the primary sponsor to take on responsibilities of
      sponsorship. A secondary sponsor may have agreed to take on all the responsibilities
      of sponsorship jointly with the primary sponsor; or to form a group with the
      primary sponsor in which the responsibilities of sponsorship are allocated among
      the members of the group; or to act as the sponsor's legal representative in
      relation to some or all of the study sites; or to take responsibility for the
      accuracy of study registration information submitted.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Secondary Clinical Study Sponsor
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Activity
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C71473
    :notation: Study Activity
    :definition: An action, undertaking, or event, which is anticipated to be performed
      or observed, or was performed or observed, according to the study protocol during
      the execution of the study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Activity
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Protocol Version Purpose Statement
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C94122
    :notation: Study Rationale
    :definition: A statement describing the overall rationale of the study. This field
      describes the contribution of this study to product development, i.e., what
      knowledge is being contributed from the conduct of this study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Protocol Version Purpose Statement
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Study Purpose
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Schematic
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C93682
    :notation: Study Schematic Diagram
    :definition: A diagram that outlines the decision points (e.g. randomization,
      response evaluation) that define the different paths a participant could take
      through the study. This is typically a block diagram and may include epochs,
      timing of randomization, treatment arms, and duration of treatments.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Schematic
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Study Schema
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Type
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C142175
    :notation: Study Type
    :definition: Describes the role the study plays in determining the interventions
      a subject receives.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Type
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Study Type
      :tagged: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Entities Clinical Study Attribute Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Clinical Study Attribute Terminology
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Clinical Trial Attribute Terminology
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C139020
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C139020
  :notation: Clinical Trial Attribute Terminology
  :definition: A terminology value set relevant to the attributes of the clinical
    trial entity.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Country of Recruitment
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C139170
    :notation: Country of Recruitment
    :definition: The country in which participants are located when enrolling in a
      trial or study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Country of Recruitment
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Date of First Enrollment into Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C139171
    :notation: Date of First Enrollment
    :definition: Date or date and time of first subject enrollment into a study, as
      verifiable by a convention that is consistent with authoritative regulatory
      criteria. Compare with study start. [Modified from ICH E3] (CDISC Glossary)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Date of First Enrollment into Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Exclusion Criteria
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25370
    :notation: Exclusion Criteria
    :definition: List of characteristics in a protocol, any one of which may exclude
      a potential subject from participation in a study. (CDISC glossary)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Exclusion Criteria
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Inclusion Criteria
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25532
    :notation: Inclusion Criteria
    :definition: 'The criteria in a protocol that prospective subjects must meet to
      be eligible for participation in a study. NOTE: Exclusion and inclusion criteria
      define the study population. See also exclusion criteria. (CDISC glossary)'
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Inclusion Criteria
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Planned Trial Duration
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C127796
    :notation: Planned Trial Duration
    :definition: The approximate period of time over which the clinical trial is expected
      to occur.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Planned Trial Duration
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Planned Trial Duration
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Primary Endpoint
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C94496
    :notation: Primary Endpoint
    :definition: The principal endpoint associated with the study or trial.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Primary Endpoint
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Primary Study Sponsor Name
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C139168
    :notation: Primary Sponsor Name
    :definition: The name of the entity that is considered the primary sponsor for
      the trial or study. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Primary Study Sponsor Name
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Secondary Endpoint
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C139173
    :notation: Secondary Endpoint
    :definition: An auxiliary endpoint associated with the study or trial.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Secondary Endpoint
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Secondary Study Sponsor Name
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C139169
    :notation: Secondary Sponsor Name
    :definition: The name of the entity that is considered the secondary sponsor for
      the trial or study. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Secondary Study Sponsor Name
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Source of Monetary or Material Support for Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C139167
    :notation: Source of Monetary or Material Support for Study
    :definition: The major organizations providing monetary or material support for
      the conduct of the trial, including, but not limited to, funding, design, implementation,
      data analysis and reporting. (EudraCT)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Source of Monetary or Material Support for Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Target Sample Size
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C139172
    :notation: Target Sample Size
    :definition: The total number of planned participants in a study or trial.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Target Sample Size
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Therapeutic Area
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C101302
    :notation: Therapeutic Area
    :definition: A knowledge field that focuses on research and development of specific
      treatments for diseases and pathologic findings, as well as prevention of conditions
      that negatively impact the health of an individual. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Therapeutic Area
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Therapeutic Area
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Trials Design
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15787
    :notation: Trial Design
    :definition: The detailed planning of a study of the safety, efficacy, or optimum
      dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or
      prophylactic drugs, devices, or techniques selected according to predetermined
      criteria of eligibility and observed for predefined evidence of favorable and
      unfavorable effects. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Trials Design
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Trial Indication
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C112038
    :notation: Trial Disease/Condition Indication
    :definition: The condition, disease or disorder that the clinical trial is intended
      to investigate or address.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Trial Indication
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Disease/Condition Indication
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Study by Intent
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49652
    :notation: Trial Intent
    :definition: The planned purpose of the therapy, device, or agent under study
      in the clinical trial.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Study by Intent
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Intent Type
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Trial Phase
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C48281
    :notation: Trial Phase
    :definition: Any defined stage in the lifecycle of a clinical trial.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Trial Phase
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase Classification
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Trial Primary Objective
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C85826
    :notation: Trial Primary Objective
    :definition: The principal purpose of the trial.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Trial Primary Objective
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Primary Objective
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Trial Registration Indicator
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C139166
    :notation: Trial Registration Indicator
    :definition: An indication as to whether the clinical trial has been registered
      with a trial registry system.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Trial Registration Indicator
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Trial Secondary Objective
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C85827
    :notation: Trial Secondary Objective
    :definition: The auxiliary purpose of the trial.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Trial Secondary Objective
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Secondary Objective
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Trial Site
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C85838
    :notation: Trial Site
    :definition: Any healthcare organization, institution, facility or provider directly
      involved in conducting or facilitating a particular clinical trial. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Trial Site
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Investigative Site
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Investigator Site
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Trial Type
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49660
    :notation: Trial Type
    :definition: The type of primary outcome or endpoint that the protocol is designed
      to evaluate. (clinicaltrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Trial Type
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Scope
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Type
      :tagged: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Entities Clinical Trial Attribute Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Clinical Trial Attribute Terminology
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Intervention Model Response
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C99076
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C99076
  :notation: INTMODEL
  :definition: A terminology codelist relevant to the trial design developed to compare
    treatment groups.
  :extensible: true
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Crossover Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C82637
    :notation: CROSS-OVER
    :definition: Participants receive one of two or more alternative intervention(s)
      during the initial epoch of the study and receive other intervention(s) during
      the subsequent epoch(s) of the study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Crossover Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Factorial Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C82638
    :notation: FACTORIAL
    :definition: Two or more interventions, each alone or in combination, are evaluated
      in parallel against a control group. This study design allows for the comparison
      of active drug to placebo, presence of drug-drug interactions, and comparison
      of active drugs against each other.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Factorial Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Parallel Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C82639
    :notation: PARALLEL
    :definition: Participants are assigned to one of two or more treatment groups
      in parallel for the duration of the study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Parallel Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Group Sequential Design
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C142568
    :notation: SEQUENTIAL
    :definition: Groups of participants are assigned to receive interventions based
      on prior milestones being reached in the study. (clinicaltrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Group Sequential Design
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Single Group Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C82640
    :notation: SINGLE GROUP
    :definition: All trial participants are assigned to a single treatment group for
      the duration of the study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Single Group Study
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC SDTM Intervention Model Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Intervention Model Response
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: No Yes Response
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C66742
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C66742
  :notation: NY
  :definition: A term that is used to indicate a question with permissible values
    of yes/no/unknown/not applicable.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: 'No'
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49487
    :notation: N
    :definition: The non-affirmative response to a question. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: 'No'
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: 'No'
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Not Applicable
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C48660
    :notation: NA
    :definition: Determination of a value is not relevant in the current context.
      (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Not Applicable
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: NA
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Not Applicable
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Unknown
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C17998
    :notation: U
    :definition: Not known, not observed, not recorded, or refused. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Unknown
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: U
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: UNK
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Unknown
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: 'Yes'
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49488
    :notation: Y
    :definition: The affirmative response to a question. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: 'Yes'
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: 'Yes'
      :tagged: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC SDTM Yes No Unknown or Not Applicable Response Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: No Yes Response
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Observational Study Model
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C127259
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C127259
  :notation: OBSSMO
  :definition: The terminology relevant to the trial design for observational studies.
  :extensible: true
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Case-Control Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15197
    :notation: CASE CONTROL
    :definition: A study that compares groups of people with generally similar characteristics,
      those with the condition under study (case) and those without the condition
      under study (control).
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Case-Control Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Observational Case-Crossover Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C127779
    :notation: CASE CROSSOVER
    :definition: A study in which the subject characteristics of the case, immediately
      prior to disease onset (sometimes called the hazard period), are compared to
      characteristics of same case at a prior time (i.e., control period). (ClinicalTrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Observational Case-Crossover Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Case Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15362
    :notation: CASE ONLY
    :definition: A study in which the subject with the condition under study (the
      case) is compared against a theoretical/historical model of distribution that
      serves as a control.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Case Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Cohort Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15208
    :notation: COHORT
    :definition: A study in which subjects are grouped based on a predefined personal
      or administrative characteristic.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Cohort Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Ecologic or Community Based Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C127780
    :notation: ECOLOGIC OR COMMUNITY
    :definition: A study in which geographically distinct study populations are compared
      with respect to a particular outcome.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Ecologic or Community Based Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Family Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15407
    :notation: FAMILY BASED
    :definition: A study in which related or non-related family members are compared
      with respect to a particular outcome.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Family Study
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC SDTM Observational Study Model Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Observational Study Model
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Participant Allocation Response
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C147068
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C147068
  :notation: Participant Allocation Response
  :definition: A terminology codelist for the method of assigning participants, or
    subjects, to groups or categories within a clinical study.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Nonrandomized Clinical Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C93043
    :notation: Nonrandomized
    :definition: Participants are expressly assigned to intervention groups through
      a non-random method. (clinicaltrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Nonrandomized Clinical Trial
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Not Applicable
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C48660
    :notation: Not Applicable
    :definition: Determination of a value is not relevant in the current context.
      (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Not Applicable
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: NA
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Not Applicable
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Randomization
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25196
    :notation: Randomized
    :definition: 'The process of assigning trial subjects to treatment or control
      groups using an element of chance to determine the assignments in order to reduce
      bias. NOTE: Unequal randomization is used to allocate subjects into groups at
      a differential rate; for example, three subjects may be assigned to a treatment
      group for every one assigned to the control group. [ICH E6 1.48] See also balanced
      study. (CDISC glossary)'
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Randomization
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial is Randomized
      :tagged: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Subject Allocation Response Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Participant Allocation Response
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Physical Address Attribute Terminology
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C132308
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C132308
  :notation: Physical Address Attribute Terminology
  :definition: A terminology value set relevant to the attributes of the physical
    address entity.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: City
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25160
    :notation: City
    :definition: A relatively large and/or densely populated area of human habitation
      with administrative or legal status that may be specified as a component of
      a postal address.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: City
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Country
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25464
    :notation: Country
    :definition: A sovereign nation occupying a distinct territory and ruled by an
      autonomous government.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Country
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Locality
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C87189
    :notation: Geographic Locality
    :definition: A distinct geographic area in the immediate vicinity of a particular
      place, such as a city, neighborhood or district.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Locality
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Geographic Area
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C16632
    :notation: Geographic Region
    :definition: Any demarcated area of the Earth; may be determined by both natural
      and human boundaries, such as a state or province.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Geographic Area
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Postal Code
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25621
    :notation: Postal Code
    :definition: An alphanumeric code assigned to a mail delivery area.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Postal Code
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Province
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25632
    :notation: Province
    :definition: A sub-division of a country created by the central government for
      administrative purposes. Provinces are usually, but not always, less autonomous
      than states, and must obey the laws of the central government.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Province
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: State
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C87194
    :notation: State
    :definition: A sub-division of a country that forms part of a federal union. States
      are usually, but not always, more autonomous than provinces and may have different
      laws from the central government.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: State
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Street Address
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25690
    :notation: Street Address
    :definition: The street name and building number where an entity is located.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Street Address
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Entities Physical Address Attribute Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Physical Address Attribute Terminology
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Protocol Contact Role Response
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C154681
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C154681
  :notation: Protocol Contact Role Response
  :definition: The terminology relevant to the role that the individual or entity
    plays with respect to being a contact within a study protocol.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Biostatistician
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C154709
    :notation: Biostatistician
    :definition: A person who is responsible for the statistical aspects of the clinical
      or pre-clinical study. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Biostatistician
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Informaticist
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C154708
    :notation: Clinical Informaticist
    :definition: An individual that designs, implements, evaluates and/or analyzes
      information technology in a healthcare or research setting. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Informaticist
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Clinical Informatician
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Coordinator
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C51811
    :notation: Clinical Research Coordinator
    :definition: A person to whom a clinical investigator delegates routine administrative
      requirements of a protocol. The duties and responsibilities of a clinical research
      coordinator may vary across different infrastructures. Generally, the coordinator
      manages the subject's clinical trial participation and provides a vital linkage
      between the subject, the investigator, and the sponsor. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Coordinator
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: CRC
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Public Queries Study Contact
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C127526
    :notation: Contact for Public Queries
    :definition: The study contact person who is responsible for questions from the
      public.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Public Queries Study Contact
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Coordinating Investigator
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C51818
    :notation: Coordinating Investigator
    :definition: An investigator assigned the responsibility for the coordination
      of investigators at different centers participating in a multi-center trial.
      While a single-center study would not include a coordinating investigator, the
      investigator at the site would fulfill the same responsibilities as a principal
      investigator. (after ICH E6)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Coordinating Investigator
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Data Manager
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C51820
    :notation: Data Manager
    :definition: An individual who is responsible for the development and implementation
      of architectures, policies and procedures for the effective management of data
      across its business lifecycle.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Data Manager
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Investigator
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25936
    :notation: Investigator
    :definition: A person responsible for the conduct of the clinical trial at a trial
      site. If a trial is conducted by a team of individuals at the trial site, the
      investigator is the responsible leader of the team and may be called the principle
      investigator.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Investigator
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Legal Representative for the Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C127532
    :notation: Legal Representative for the Study
    :definition: An individual with expertise in the law who provides legal counsel
      and representation for a study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Legal Representative for the Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Medical Monitor
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C51836
    :notation: Medical Monitor
    :definition: A sponsor representative who has medical authority for the evaluation
      of the safety aspects of a clinical trial. (CDISC Glossary)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Medical Monitor
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: National Coordinating Investigator
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C154706
    :notation: National Coordinating Investigator
    :definition: In the case of a multinational study, a person who has the responsibilities
      of the sponsor of the study in his/her country and will be responsible for the
      coordination of the principal investigators at different sites within that member
      state. (EMA)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: National Coordinating Investigator
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Primary Clinical Study Sponsor
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C70794
    :notation: Primary Sponsor
    :definition: The individual, organization, group or other legal person taking
      responsibility for securing the arrangements to initiate and/or manage a study
      (including arrangements to ensure that the study design meets appropriate standards
      and to ensure appropriate conduct and reporting). In commercial trials, the
      primary sponsor is normally the main applicant for regulatory authorization
      to begin the study. It may or may not be the main funder. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Primary Clinical Study Sponsor
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Principal Investigator
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C19924
    :notation: Principal Investigator
    :definition: A person who has the primary responsibility for the conduct of a
      clinical study and study-related personnel at a study site. While a single-center
      study would not include a coordinating investigator, the investigator at the
      site would fulfill the same responsibilities as a principal investigator.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Principal Investigator
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Secondary Clinical Study Sponsor
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C70795
    :notation: Secondary Sponsor
    :definition: Additional individuals, organizations or other legal persons, if
      any, that have agreed with the primary sponsor to take on responsibilities of
      sponsorship. A secondary sponsor may have agreed to take on all the responsibilities
      of sponsorship jointly with the primary sponsor; or to form a group with the
      primary sponsor in which the responsibilities of sponsorship are allocated among
      the members of the group; or to act as the sponsor's legal representative in
      relation to some or all of the study sites; or to take responsibility for the
      accuracy of study registration information submitted.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Secondary Clinical Study Sponsor
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Study Sponsor
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C70793
    :notation: Sponsor
    :definition: An entity that is responsible for the initiation, management, and/or
      financing of a clinical study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Study Sponsor
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Clinical Study Sponsor
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Sponsor
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Study Sponsor
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Chair
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C51878
    :notation: Study Chair
    :definition: A person who has overall responsibility for the technical conduct
      of a study, as well as for the interpretation, analysis, documentation and reporting
      of results, and represents the single point of study control. (FDA)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Chair
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Study Director
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Subinvestigator
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C54622
    :notation: Subinvestigator
    :definition: Any member of the clinical trial team designated and supervised by
      the investigator at a trial site to perform critical trial-related procedures
      and/or to make important trial-related decisions (e.g., associates, residents,
      research fellows). (ICH)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Subinvestigator
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Technical Lead
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C154707
    :notation: Technical Lead
    :definition: An individual who is responsible for the delivery of technical aspects
      of a project. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Technical Lead
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Entities Protocol Contact Role Response Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Protocol Contact Role Response
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Protocol Entity Terminology
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C132310
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C132310
  :notation: Protocol Entity Terminology
  :definition: A terminology value set relevant to the entities within a protocol.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15206
    :notation: Clinical Study
    :definition: 'A clinical study involves research using human volunteers (also
      called participants) that is intended to add to medical knowledge. There are
      two main types of clinical studies: clinical trials (also called interventional
      studies) and observational studies. [ClinicalTrials.gov] See also clinical trial.
      (CDISC Glossary)'
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C71104
    :notation: Clinical Trial
    :definition: 1) A research investigation involving human subjects that is designed
      to answer specific questions about the safety and efficacy of a biomedical intervention
      (drug, treatment, device) or new ways of using a known drug, treatment, or device).
      2) A research study in which one or more human subjects are prospectively assigned
      to one or more interventions (which may include placebo or other control) to
      evaluate the effects of those interventions on health-related biomedical or
      behavioral outcomes.(1. modified from ICH E6 Glossary, Directive 2001/20/EC.
      2. NIH revised definition 2015) (CDISC Glossary)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Trial
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Address
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25407
    :notation: Physical Address
    :definition: A standardized representation of the location of a person, business,
      building, or organization. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Address
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Contact Information
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C154705
    :notation: Study Contact Information
    :definition: Information regarding the means of contacting a person or group that
      performs a function within a clinical study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Contact Information
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Design
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15320
    :notation: Study Design
    :definition: A plan detailing how a study will be performed in order to represent
      the phenomenon under examination, to answer the research questions that have
      been asked, and informing the statistical approach.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Design
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Monitoring
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C142707
    :notation: Study Monitoring
    :definition: The act of overseeing the progress of a clinical study and of ensuring
      that it is conducted, recorded, and reported in accordance with the protocol,
      standard operating procedures (SOPs), good clinical practice (GCP), and regulatory
      requirement(s) where applicable. [after ICH E6 Glossary]
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Monitoring
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Population
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C70833
    :notation: Study Population
    :definition: A group of individuals taken from the general population who share
      a set of common characteristics, such as age, sex, or health condition, precisely
      defined in the study protocol. This is a population to which the study results
      could be reasonably generalized.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Population
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Protocol
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C70817
    :notation: Study Protocol
    :definition: The formal plan of an experiment or research activity, including
      the objective, rationale, design, materials and methods for the conduct of the
      study, intervention description, and method of data analysis.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Protocol
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Entities Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Protocol Entity Terminology
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Randomization Type Response
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C147069
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C147069
  :notation: Randomization Type Response
  :definition: A terminology codelist relevant to the types of randomization schemas
    associated with a randomized controlled trial.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Adaptive Randomization
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147126
    :notation: Adaptive Randomization
    :definition: A type of randomization schema in which the group assignment probability
      of a participant is adjusted based on the group assignments of those participants
      already randomized in the trial.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Adaptive Randomization
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Block Randomization
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147127
    :notation: Block Randomization
    :definition: A type of adaptive randomization in which a pre-specified number
      of participants is assigned to a block containing the same pre-specified number
      of balanced group assignments in random order.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Block Randomization
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Constrained Randomization
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Minimization Randomization
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147143
    :notation: Minimization Randomization
    :definition: A type of adaptive randomization in which the participant is assigned
      to the treatment group in an attempt to minimize imbalances in the number of
      participants for each stratification covariate across treatment groups.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Minimization Randomization
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Covariate Adaptive Randomization
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Simple Randomization
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147144
    :notation: Simple Randomization
    :definition: A type of randomization schema in which each participant has the
      same chance of being randomized into any one group as all other participants.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Simple Randomization
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Unrestricted Randomization
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Stratified Randomization
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147145
    :notation: Stratified Randomization
    :definition: A type of block randomization in which participants are stratified
      into groups based on prognostic variables and then randomized into balanced
      treatment groups.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Stratified Randomization
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Unequal Randomization
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C142743
    :notation: Unequal Randomization
    :definition: A type of randomization schema in which unequal numbers of participants
      are purposely assigned to multiple treatment groups.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Unequal Randomization
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Randomization Type Response Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Randomization Type Response
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Study Contact Information Attribute Terminology
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C154682
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C154682
  :notation: Study Contact Information Attribute Terminology
  :definition: A terminology value set relevant to the attributes of the study contact
    information.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Academic Degree
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25354
    :notation: Academic Degree
    :definition: An academic rank conferred by a college, university, or other postsecondary
      education institution as official recognition for the successful completion
      of a program of studies.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Academic Degree
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Person Name
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25191
    :notation: Contact Name
    :definition: A word or group of words indicating the identity of a person usually
      consisting of a first (personal) name and a last (family) name with an optional
      middle name. In some cultural traditions the family name comes first.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Person Name
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Individual's Name
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Person Name
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: E-mail Address
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C42775
    :notation: E-mail Address
    :definition: A text string identifier for a location to which electronic mail
      can be delivered. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: E-mail Address
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Email Address
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Fax Number
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C42879
    :notation: Fax Number
    :definition: A telephone number that is used for identifying a specific fax machine
      in a telephone network.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Fax Number
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Facsimile Number
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Organizational Affiliation Name
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C154704
    :notation: Organizational Affiliation
    :definition: The name of the organization or entity that the person or group has
      an established relationship with.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Organizational Affiliation Name
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Address
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25407
    :notation: Physical Address
    :definition: A standardized representation of the location of a person, business,
      building, or organization. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Address
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Role
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C48835
    :notation: Role
    :definition: The usual or expected function of something; the part something plays
      in an action or event. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Role
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Telephone Number
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C40978
    :notation: Telephone Number
    :definition: A sequence of decimal digits (0-9) that is used for identifying a
      specific telephone line or other device in a telephone network.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Telephone Number
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Phone Number
      :tagged: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Entities Study Contact Information Attribute Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Study Contact Information Attribute Terminology
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Study Design Attribute Terminology
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C147066
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C147066
  :notation: Study Design Attribute Terminology
  :definition: A terminology value set relevant to the attributes of the study design
    entity.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Blinded
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49068
    :notation: Blinding
    :definition: A process to limit bias by preventing subjects and/ or study personnel
      from identifying which treatments or procedures are administered, or from learning
      the results of tests and measures undertaken as part of a clinical investigation.
      (CDISC Glossary)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Blinded
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Masking
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Intervention Model
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C98746
    :notation: Interventional Study Design
    :definition: The general design of the strategy for assigning interventions to
      participants in a clinical study. (clinicaltrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Intervention Model
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Intervention Model
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Observational Study Model
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147138
    :notation: Observational Study Design
    :definition: The general design of the strategy for identifying and following
      up with participants during observational studies. (clinicaltrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Observational Study Model
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Observation Model
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Design Description
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147139
    :notation: Overall Study Design
    :definition: Summary description of the overall study plan and design, should
      include treatments studied, population studied, level and method of blinding/unmasking,
      kind of controls, method of assignment to treatment, sequence and duration of
      study periods, any safety, data monitoring or special steering or evaluation
      committees, and interim analyses. (ICH E3)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Design Description
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Overall Design
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Study Design Description
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Study Design Overview
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Summary of Study Design
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Allocation
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C52580
    :notation: Participant Allocation
    :definition: The process of assigning participants to particular treatment groups
      or cohorts in a clinical study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Allocation
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Subject Allocation
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Planned Number of Arms
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C98771
    :notation: Planned Number of Arms
    :definition: The planned number of intervention groups.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Planned Number of Arms
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Planned Number of Arms
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Planned Number of Cohorts
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147137
    :notation: Planned Number of Cohorts
    :definition: The planned number of study groups.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Planned Number of Cohorts
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Planned Subject Number
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49692
    :notation: Planned Number of Participants
    :definition: The planned number of subjects to be entered in a clinical trial.
      (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Planned Subject Number
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Anticipated Enrollment
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Planned Enrollment
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Planned Number of Subjects
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Target Enrollment
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Randomization Method
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147140
    :notation: Randomization Type
    :definition: The type of randomization method used to assign particpants to treatment
      groups or cohorts.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Randomization Method
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Stratification
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C25689
    :notation: Stratification
    :definition: Grouping defined by important prognostic factors measured at baseline.
      (ICH E9)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Stratification
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Stratification Factors
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C16153
    :notation: Stratification Factor
    :definition: Selected factors that are used during randomization to ensure there
      is balance of these factors across all subjects within each arm of a study.
      The subject level values of these factors may be used as fixed effects in statistical
      models and for sensitivity analyses.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Stratification Factors
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Stratification Factor
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Design Rationale
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C142705
    :notation: Study Design Rationale
    :definition: Reason(s) for choosing the study design. This may include reasons
      for the choice of control or comparator, as well as the scientific rationale
      for the study design.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Design Rationale
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Research Hypothesis
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C142668
    :notation: Study Hypothesis
    :definition: A supposition or proposal made to explain certain observations or
      facts, which requires further investigation or exploration within a clinical
      study. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Research Hypothesis
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Primary Purpose
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147141
    :notation: Study Primary Purpose
    :definition: The principal reason or intention for the execution of an interventional
      or non-interventional clinical study. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Primary Purpose
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Secondary Purpose
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147142
    :notation: Study Secondary Purpose
    :definition: The ancillary reason or intention for the execution of an interventional
      or non-interventional clinical study. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Secondary Purpose
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Trial Blinding Schema
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49658
    :notation: Trial Blinding Schema
    :definition: The type of experimental design used to describe the level of awareness
      of the clinical trial subjects and/or investigators of the intervention(s) that
      they are receiving and/or administering.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Trial Blinding Schema
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Blinding Schema
      :tagged: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Entities Study Design Attribute Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Study Design Attribute Terminology
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Study Monitoring Attribute Terminology
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C163026
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C163026
  :notation: Study Monitoring Attribute Terminology
  :definition: A terminology value set relevant to the attributes of the study monitoring
    entity.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Trial Monitoring Plan
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C115753
    :notation: Clinical Monitoring Plan
    :definition: A description of the strategy, methods, responsibilities, and requirements
      for monitoring the study. (ICH E6(R2))
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Trial Monitoring Plan
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Data Monitoring
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C142488
    :notation: Data Monitoring
    :definition: Review of study data for completeness, consistency, and accuracy
      for the duration of the study lifecycle.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Data Monitoring
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Data and Safety Monitoring Plan
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C163406
    :notation: Data and Safety Monitoring Plan
    :definition: A written plan that prospectively identifies and documents monitoring
      activities intended to protect the safety of the participants, the validity
      of the data and the integrity of the research study. The DSMP may also identify
      when to terminate a participant's participation (i.e. individual stopping rules)
      and/or the appropriate termination of a study (i.e. study stopping rules). (Mayo
      Clinic)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Data and Safety Monitoring Plan
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: DSMP
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Data Safety Monitoring Plan
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Safety Data Monitoring Plan
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: GCP Adherence Statement
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C163407
    :notation: GCP Adherence Statement
    :definition: A written message that asserts, affirms, or declares that the study
      is conducted in accordance with Good Clinical Practice (GCP).
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: GCP Adherence Statement
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Good Clinical Practice Adherence Statement
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Risk Based Monitoring
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C142674
    :notation: Risk Monitoring
    :definition: A systematic, prioritized approach that involves identifying, assessing,
      monitoring and mitigating the risks that could affect the quality of the study
      or safety of the study participants.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Risk Based Monitoring
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Safety Data Monitoring
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C163408
    :notation: Safety Data Monitoring
    :definition: Review of cumulative safety data to identify possible safety concerns.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Safety Data Monitoring
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Safety Monitoring
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C163409
    :notation: Safety Monitoring
    :definition: Review of safety data to ensure safety of the individuals who are
      participating in the study, or to identify potential safety concerns for the
      duration of the study lifecycle.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Safety Monitoring
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Monitoring Statement
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C163410
    :notation: Study Monitoring Statement
    :definition: A written message that asserts, affirms, or declares that the study
      will be monitored in adherence to a clinical monitoring plan and in accordance
      with Good Clinical Practice (GCP).
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Monitoring Statement
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Suicidal Risk Monitoring
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C163411
    :notation: Suicidal Risk Monitoring
    :definition: A systematic approach to identify and assess the risks of participant
      suicidal ideation and/or suicide.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Suicidal Risk Monitoring
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Trials, Monitoring
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15789
    :notation: Trial Monitoring
    :definition: The act of overseeing the progress of a clinical trial and of ensuring
      that it is conducted, recorded, and reported in accordance with the protocol,
      standard operating procedures (SOPs), good clinical practice (GCP), and the
      applicable regulatory requirement(s). [ICH E6 Glossary]
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Trials, Monitoring
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Study Monitoring Attribute Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Study Monitoring Attribute Terminology
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Study Population Attribute Terminology
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C160921
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C160921
  :notation: Study Population Attribute Terminology
  :definition: A terminology value set relevant to the attributes of the study population
    entity.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Comorbid Condition
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161320
    :notation: Comorbid Condition
    :definition: Medical or health condition that is concomitant or concurrent with
      the primary condition or disease under study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Comorbid Condition
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Condition or Disease under Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161319
    :notation: Condition or Disease under Study
    :definition: Primary disease(s) or condition(s) being studied in the trial, or
      the focus of the study. (clinicaltrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Condition or Disease under Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Control Group
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C28143
    :notation: Control Group
    :definition: A study population that is defined for the purpose of comparison
      to the treatment group in a controlled trial. In an epidemiological study, a
      study population that does not have the outcome of interest.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Control Group
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Demographic Group
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161324
    :notation: Demographic Group
    :definition: A descriptive characterization of the study population (e.g., age,
      sex, race, education, etc.).
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Demographic Group
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Experimental Group
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161323
    :notation: Experimental Group
    :definition: A study population that receives the intervention that is the focus
      of the study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Experimental Group
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Female of Childbearing Potential
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161316
    :notation: Females of Childbearing Potential
    :definition: Female study subjects or patients who have the potential to become
      pregnant, i.e., those who have experienced menarche and who have not undergone
      surgical sterilization and are not postmenopausal.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Female of Childbearing Potential
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: FOCBP
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: WOCBP
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Women of Childbearing Potential
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Health Status
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C16669
    :notation: General Health Status
    :definition: The state of a subject's mental or physical condition.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Health Status
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Healthy Subject
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49651
    :notation: Healthy Volunteer
    :definition: An individual who is or becomes a participant in a research study
      and has no significant health-related issues. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Healthy Subject
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Healthy Subject
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Justification of Special Population
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161318
    :notation: Justification of Special Population
    :definition: An explanation with defensible proof as to the reason why a special
      population of subjects is included in the clinical study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Justification of Special Population
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Population Rationale
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161317
    :notation: Population Rationale
    :definition: An explanation as to the logical reasons for why a specific population
      of subjects is being considered for inclusion in a clinical study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Population Rationale
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Reference Group
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161321
    :notation: Reference Group
    :definition: The study population that is defined for the purpose of comparison
      to the population under investigation.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Reference Group
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Reference Group for Study Sample Population
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Target Study Population
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C142728
    :notation: Target Study Population
    :definition: The population within the general population for which the study
      results can be generalized.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Target Study Population
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Target Population
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Treatment Group
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161322
    :notation: Treatment Group
    :definition: A study population that receives an intervention(s) within a trial.
      This could include the investigational product(s) or a comparator (e.g., placebo
      or an approved intervention).
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Treatment Group
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Vulnerable Subjects
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C142747
    :notation: Vulnerable Population
    :definition: Individuals whose willingness to volunteer in a clinical trial may
      be unduly influenced by the expectation, whether justified or not, of benefits
      associated with participation, or of a retaliatory response from senior members
      of a hierarchy in case of refusal to participate. Examples include subordinate
      members of a group with a hierarchical structure, patients with incurable diseases,
      persons in nursing homes, unemployed or impoverished persons, patients in emergency
      situations, ethnic minority groups, homeless persons, nomads, refugees, minors,
      and those incapable of giving consent. (ICH)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Vulnerable Subjects
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Study Population Attribute Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Study Population Attribute Terminology
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Study Protocol Attribute Terminology
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C132309
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C132309
  :notation: Study Protocol Attribute Terminology
  :definition: A terminology value set relevant to the attributes of the study protocol
    entity.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Alternate Protocol Identifier
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C132344
    :notation: Alternate Protocol Identifier
    :definition: A unique code assigned by an affiliated governing body or other organization
      that identifies a specific protocol (e.g., grant number, national number).
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Alternate Protocol Identifier
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Brief Protocol Title
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C132345
    :notation: Brief Protocol Title
    :definition: The short descriptive name for the protocol.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Brief Protocol Title
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Abbreviated Protocol Title
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Official Protocol Title
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C132346
    :notation: Official Protocol Title
    :definition: The formal descriptive name for the protocol.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Official Protocol Title
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Protocol Amendment
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C132347
    :notation: Protocol Amendment
    :definition: A written description of a change(s) to, or formal clarification
      of, a protocol. (ICH E6)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Protocol Amendment
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Protocol Author
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C51853
    :notation: Protocol Author
    :definition: A person who is the writer of a structured research study protocol.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Protocol Author
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Clinical Trial Protocol Synopsis
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C115628
    :notation: Protocol Synopsis
    :definition: A scientific summary of the key points of the protocol.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Clinical Trial Protocol Synopsis
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Protocol Scientific Summary
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Protocol Document Version Public Title
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C94105
    :notation: Public Protocol Title
    :definition: The descriptive name of the protocol that is intended for the lay
      public, written in easily understood language.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Protocol Document Version Public Title
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Registry Protocol Identifier
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C132348
    :notation: Registry Protocol Identifier
    :definition: A unique code assigned by a clinical trial registry that identifies
      a specific protocol.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Registry Protocol Identifier
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Schedule of Activities
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C132349
    :notation: Schedule of Activities
    :definition: A standardized representation of planned clinical trial activities
      including interventions (e.g., administering drug, surgery) and study administrative
      activities (e.g., obtaining informed consent, distributing clinical trial material
      and diaries, randomization) as well as assessments. (CDISC Glossary)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Schedule of Activities
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Schedule of Events
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: SoA
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Scientific Protocol Title
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C132350
    :notation: Scientific Protocol Title
    :definition: A more extensive descriptive name of the protocol that is intended
      for medical professionals, written using medical and scientific language.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Scientific Protocol Title
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Sponsor Protocol Identifier
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C132351
    :notation: Sponsor Protocol Identifier
    :definition: A unique code assigned by the sponsor that identifies a specific
      protocol.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Sponsor Protocol Identifier
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Sponsor Protocol Code
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Sponsor Protocol Number
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Protocol Version Acronym
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C94108
    :notation: Study Acronym
    :definition: A word or words formed from the beginning letters or a combination
      of syllables and letters of a compound term, which identifies a clinical study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Protocol Version Acronym
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Acronym
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Study Protocol Version
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C93490
    :notation: Study Protocol Version
    :definition: A plan at a particular point in time for a formal investigation to
      assess the utility, impact, pharmacological, physiological, and/or psychological
      effects of a particular treatment, procedure, drug, device, biologic, food product,
      cosmetic, care plan, or subject characteristic. (BRIDG)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Study Protocol Version
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Protocol Approval Date
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C132352
    :notation: Study Protocol Version Approval Date
    :definition: The date on which a version of the protocol was finalized or approved
      by the sponsor.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Protocol Approval Date
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Entities Study Protocol Attribute Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Study Protocol Attribute Terminology
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Study Purpose Response
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C147067
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C147067
  :notation: Study Purpose Response
  :definition: A terminology codelist relevant to the reason(s) or intention(s) for
    the execution of an interventional or non-interventional clinical study.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Basic Research
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15714
    :notation: Basic Science
    :definition: A type of study designed to examine the basic mechanism of action
      (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Basic Research
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Basic Research
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Device Feasibility Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C139174
    :notation: Device Feasibility
    :definition: An intervention of a device product is being evaluated to determine
      the feasibility of the product or to test a prototype device and not health
      outcomes. Such studies are conducted to confirm the design and operating specifications
      of a device before beginning a full clinical trial. (ClinicalTrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Device Feasibility Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Diagnosis
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15220
    :notation: Diagnosis
    :definition: The investigation, analysis and recognition of the presence and nature
      of disease, condition, or injury from expressed signs and symptoms; also, the
      scientific determination of any kind; the concise results or summary of such
      an investigation. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Diagnosis
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Diagnostic
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Exploratory Research
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147146
    :notation: Exploratory Research
    :definition: Any action or process to perform research on a hypothetical or theoretical
      idea in order to determine whether the phenomena is new (which may lead to additional
      studies) or can be explained by an existing and well-substantiated theory. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Exploratory Research
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Health Services Research
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15245
    :notation: Health Services Research
    :definition: A type of study designed to evaluate the delivery, processes, management,
      organization or financing of health care. (ClinicalTrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Health Services Research
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Hypothesis Generation
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C147147
    :notation: Hypothesis Generation
    :definition: Any action or process to create a tentative proposal to explain certain
      observations or facts, and which requires further investigation to be verified.
      (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Hypothesis Generation
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Preventive Intervention
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15843
    :notation: Prevention
    :definition: Any action or response to modify or stop the development of a disease.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Preventive Intervention
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Prophylaxis
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Disease Screening
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15419
    :notation: Screening
    :definition: Any action or process to identify a condition, or risk factors for
      a condition, in humans who are not yet known to have the condition or risk factor.
      (clinicaltrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Disease Screening
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Supportive Care
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15747
    :notation: Supportive Care
    :definition: Any action or process to maximize comfort, minimize side effects,
      or mitigate against a decline in the participant's health or function. (clinicaltrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Supportive Care
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Treat
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C70742
    :notation: Treatment
    :definition: Any action or process to improve or remedy a syndrome, disease, or
      condition.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Treat
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC Protocol Study Purpose Response Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Study Purpose Response
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Study Type Response
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C99077
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C99077
  :notation: STYPE
  :definition: A terminology codelist relevant to the role the study plays in determining
    the interventions a subject receives.
  :extensible: false
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Expanded Access Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C98722
    :notation: EXPANDED ACCESS
    :definition: Studies that provide a means for obtaining an experimental drug or
      device for patients who are not adequately treated by existing therapy, who
      do not meet the eligibility criteria for enrollment, or who are otherwise unable
      to participate in another clinical study. Expanded Access studies include individual-patient
      IND, treatment IND, compassionate use, emergency use or continued access.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Expanded Access Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Interventional Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C98388
    :notation: INTERVENTIONAL
    :definition: Studies in which individuals are assigned by an investigator based
      on a protocol to receive specific interventions. Subjects may receive diagnostic,
      therapeutic or other types of interventions. The assignment of the intervention
      may or may not be random. The individuals are then followed and biomedical and/or
      health outcomes are assessed.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Interventional Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Observational Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C16084
    :notation: OBSERVATIONAL
    :definition: Studies in which biomedical and/or health outcomes are assessed in
      pre-defined groups of individuals. Subjects in the study may receive diagnostic,
      therapeutic, or other interventions, but the investigator does not assign specific
      interventions to the subjects of the study.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Observational Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Patient Registry Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C129000
    :notation: PATIENT REGISTRY
    :definition: Observational studies which include an organized system that uses
      observational methods to collect uniform data (clinical and other) prospectively
      for a population defined by a particular disorder/disease, condition (including
      susceptibility to a disorder), or exposure (including products, health care
      services, and/or procedures) and that serves a predetermined scientific, clinical,
      or policy purpose. Patient registries may be single purpose or on-going data
      collection programs that address one or more questions. (AHRQ)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Patient Registry Study
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC SDTM Study Type Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Study Type Response
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Trial Intent Type Response
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C66736
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C66736
  :notation: TINDTP
  :definition: A terminology codelist relevant to the responses for the planned purpose
    of the therapy, device, or agent under study in the clinical trial.
  :extensible: true
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Basic Research
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15714
    :notation: BASIC SCIENCE
    :definition: A type of study designed to examine the basic mechanism of action
      (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Basic Research
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Basic Research
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Cure Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49654
    :notation: CURE
    :definition: A type of study designed to evaluate intervention(s) aimed to cure
      a disease or condition.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Cure Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Device Feasibility Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C139174
    :notation: DEVICE FEASIBILITY
    :definition: An intervention of a device product is being evaluated to determine
      the feasibility of the product or to test a prototype device and not health
      outcomes. Such studies are conducted to confirm the design and operating specifications
      of a device before beginning a full clinical trial. (ClinicalTrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Device Feasibility Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Diagnosis Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49653
    :notation: DIAGNOSIS
    :definition: A type of study designed to evaluate intervention(s) aimed at identifying
      a disease or condition.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Diagnosis Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Health Services Research
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15245
    :notation: HEALTH SERVICES RESEARCH
    :definition: A type of study designed to evaluate the delivery, processes, management,
      organization or financing of health care. (ClinicalTrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Health Services Research
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Adverse Effect Mitigation Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49655
    :notation: MITIGATION
    :definition: A type of study designed to identify actions necessary to eliminate
      or reduce the risk to human life or well-being as a result of a particular medication
      or treatment regimen. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Adverse Effect Mitigation Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Prevention Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49657
    :notation: PREVENTION
    :definition: A type of study designed to identify actions necessary to permanently
      eliminate or reduce the long-term risk to human life as a result of a particular
      medication or treatment regimen.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Prevention Study
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Prophylaxis Study
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Screening Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C71485
    :notation: SCREENING
    :definition: A type of study designed to assess or examine methods of identifying
      a condition (or risk factors for a condition) in people who are not yet known
      to have the condition (or risk factor). (Clinicaltrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Screening Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Supportive Care Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C71486
    :notation: SUPPORTIVE CARE
    :definition: A type of study designed to evaluate one or more interventions where
      the primary intent is to maximize comfort, minimize side effects or mitigate
      against a decline in the subject's health or function. In general, supportive
      care interventions are not intended to cure a disease. (ClinicalTrials.gov)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Supportive Care Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Treatment Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49656
    :notation: TREATMENT
    :definition: A type of study designed to evaluate intervention(s) for treatment
      of disease, syndrome or condition.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Treatment Study
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Therapy Trial
      :tagged: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC SDTM Trial Indication Type Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Trial Intent Type Response
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Trial Phase Response
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C66737
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C66737
  :notation: TPHASE
  :definition: A terminology codelist relevant to the phase, or stage, of the clinical
    trial.
  :extensible: true
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Not Applicable
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C48660
    :notation: NOT APPLICABLE
    :definition: Determination of a value is not relevant in the current context.
      (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Not Applicable
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: NA
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Not Applicable
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase 0 Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C54721
    :notation: PHASE 0 TRIAL
    :definition: 'First-in-human trials, in a small number of subjects, that are conducted
      before Phase 1 trials and are intended to assess new candidate therapeutic and
      imaging agents. The study agent is administered at a low dose for a limited
      time, and there is no therapeutic or diagnostic intent. NOTE: FDA Guidance for
      Industry, Investigators, and Reviewers: Exploratory IND Studies, January 2006
      classifies such studies as Phase 1. NOTE: A Phase 0 study might not include
      any drug delivery but may be an exploration of human material from a study (e.g.,
      tissue samples or biomarker determinations). [Improving the Quality of Cancer
      Clinical Trials: Workshop summary-Proceedings of the National Cancer Policy
      Forum Workshop, improving the Quality of Cancer Clinical Trials (Washington,
      DC, Oct 2007)] (CDISC glossary)'
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase 0 Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: '0'
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Pre-clinical Trial
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 0
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase I Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15600
    :notation: PHASE I TRIAL
    :definition: 'The initial introduction of an investigational new drug into humans.
      Phase 1 studies are typically closely monitored and may be conducted in patients
      or normal volunteer subjects. NOTE: These studies are designed to determine
      the metabolism and pharmacologic actions of the drug in humans, the side effects
      associated with increasing doses, and, if possible, to gain early evidence on
      effectiveness. During Phase 1, sufficient information about the drug''s pharmacokinetics
      and pharmacological effects should be obtained to permit the design of well-controlled,
      scientifically valid, Phase 2 studies. The total number of subjects and patients
      included in Phase I studies varies with the drug, but is generally in the range
      of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity
      relationships, and mechanism of action in humans, as well as studies in which
      investigational drugs are used as research tools to explore biological phenomena
      or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary)'
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase I Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: '1'
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 1
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase I/II Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15693
    :notation: PHASE I/II TRIAL
    :definition: A class of clinical study that combines elements characteristic of
      traditional Phase I and Phase II trials. See also Phase I, Phase II.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase I/II Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: 1-2
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 1-2
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase II Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15601
    :notation: PHASE II TRIAL
    :definition: 'Phase 2. Controlled clinical studies conducted to evaluate the effectiveness
      of the drug for a particular indication or indications in patients with the
      disease or condition under study and to determine the common short-term side
      effects and risks associated with the drug. NOTE: Phase 2 studies are typically
      well controlled, closely monitored, and conducted in a relatively small number
      of patients, usually involving no more than several hundred subjects. [After
      FDA CDER Handbook, ICH E8] (CDISC glossary)'
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase II Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: '2'
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 2
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase II/III Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15694
    :notation: PHASE II/III TRIAL
    :definition: A class of clinical study that combines elements characteristic of
      traditional Phase II and Phase III trials.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase II/III Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: 2-3
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 2-3
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase IIa Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49686
    :notation: PHASE IIA TRIAL
    :definition: A clinical research protocol generally referred to as a pilot or
      feasibility trial that aims to prove the concept of the new intervention in
      question. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase IIa Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: 2A
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 2A
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase IIb Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49688
    :notation: PHASE IIB TRIAL
    :definition: A clinical research protocol generally referred to as a well-controlled
      and pivotal trial that aims to prove the mechanism of action of the new intervention
      in question. A pivotal study will generally be well-controlled, randomized,
      of adequate size, and whenever possible, double-blind. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase IIb Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: 2B
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 2B
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase III Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15602
    :notation: PHASE III TRIAL
    :definition: 'Phase 3. Studies are expanded controlled and uncontrolled trials.
      They are performed after preliminary evidence suggesting effectiveness of the
      drug has been obtained, and are intended to gather the additional information
      about effectiveness and safety that is needed to confirm efficacy and evaluate
      the overall benefit-risk relationship of the drug and to provide an adequate
      basis for physician labeling. NOTE: Phase 3 studies usually include from several
      hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8] (CDISC
      glossary)'
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase III Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: '3'
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 3
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase IIIa Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49687
    :notation: PHASE IIIA TRIAL
    :definition: A classification typically assigned retrospectively to a Phase III
      trial upon determination by regulatory authorities of a need for a Phase III
      B trial. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase IIIa Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: 3A
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 3A
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase IIIb Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49689
    :notation: PHASE IIIB TRIAL
    :definition: 'A subcategory of Phase III trials done near the time of approval
      to elicit additional findings. NOTE: Dossier review may continue while associated
      Phase IIIB trials are conducted. These trials may be required as a condition
      of regulatory authority approval.'
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase IIIb Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: 3B
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 3B
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase IV Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C15603
    :notation: PHASE IV TRIAL
    :definition: 'Phase 4. Postmarketing (Phase 4) studies to delineate additional
      information about the drug''s risks, benefits, and optimal use that may be requested
      by regulatory authorities in conjunction with marketing approval. NOTE: These
      studies could include, but would not be limited to, studying different doses
      or schedules of administration than were used in Phase 2 studies, use of the
      drug in other patient populations or other stages of the disease, or use of
      the drug over a longer period of time. [After FDA CDER Handbook, ICH E8] (CDISC
      glossary)'
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase IV Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: '4'
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 4
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Phase V Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C47865
    :notation: PHASE V TRIAL
    :definition: Postmarketing surveillance is sometimes referred to as Phase V.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Phase V Trial
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: '5'
      :tagged: []
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Trial Phase 5
      :tagged: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC SDTM Trial Phase Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Trial Phase Response
    :tagged: []
  :is_ordered: 
- :id: 
  :uri: {}
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Trial Type Response
  :tagged:
  - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
    :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
    :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
    :pref_label: Protocol
    :description: Protocol related information.
    :narrower: []
  :has_state: 
  :has_identifier:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
    :identifier: C66739
    :version_label: ''
    :version: 1
    :semantic_version: ''
    :has_scope: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2016-01-01T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C66739
  :notation: TTYPE
  :definition: A terminology codelist relevant to the type of primary outcome or endpoint
    that the protocol is designed to evaluate.
  :extensible: true
  :narrower:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Adhesion Performance Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C158283
    :notation: ADHESION PERFORMANCE
    :definition: A type of study designed to evaluate the strength of the bond between
      an adhesive and the application surface.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Adhesion Performance Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Alcohol Effect Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C158284
    :notation: ALCOHOL EFFECT
    :definition: A type of study designed to evaluate the effects of alcohol on investigational
      product safety and/or efficacy.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Alcohol Effect Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Bioavailability Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49664
    :notation: BIO-AVAILABILITY
    :definition: A study of the degree to which or rate at which a drug or other substance
      is absorbed or becomes available at the site of physiological activity after
      administration. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Bioavailability Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Therapeutic Equivalency Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49665
    :notation: BIO-EQUIVALENCE
    :definition: A study most often used to compare the efficacy of different formulations
      to treat a given disease. It is the testing of an old versus a new formulation
      in healthy volunteers or subjects with the disease under study and usually in
      one dose. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Therapeutic Equivalency Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Biosimilarity Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C158288
    :notation: BIOSIMILARITY
    :definition: A type of study designed to evaluate whether a biologic test article
      is highly similar in function and effect to an existing biologic that has already
      been clinically tested and approved for use.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Biosimilarity Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Device-Drug Interaction Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C158285
    :notation: DEVICE-DRUG INTERACTION
    :definition: A type of study designed to evaluate the interaction between a device
      and a drug, where the use of one may affect the disposition, function, efficacy,
      or safety of the other.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Device-Drug Interaction Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Diagnosis Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49653
    :notation: DIAGNOSIS
    :definition: A type of study designed to evaluate intervention(s) aimed at identifying
      a disease or condition.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Diagnosis Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Dose Finding Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C158289
    :notation: DOSE FINDING
    :definition: An early phase clinical study with the objective of determining the
      optimal dose of an investigational product.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Dose Finding Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Dose Proportionality Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C158290
    :notation: DOSE PROPORTIONALITY
    :definition: A type of study designed to evaluate the relationship between dose
      and resulting exposure.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Dose Proportionality Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Dose Response Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C127803
    :notation: DOSE RESPONSE
    :definition: A study of the effect of dose changes on the efficacy of a drug in
      order to determine the dose-response relationship and optimal dose of a therapy.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Dose Response Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Drug-Drug Interaction Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C158286
    :notation: DRUG-DRUG INTERACTION
    :definition: A type of study designed to evaluate the interaction between drugs,
      where the use of one may affect the disposition, efficacy, or safety of the
      other.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Drug-Drug Interaction Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Efficacy Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49666
    :notation: EFFICACY
    :definition: A study of the relative therapeutic efficacy of treatment of a disease.
      Usually this is a Phase II or III study. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Efficacy Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Food Effect Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C98729
    :notation: FOOD EFFECT
    :definition: Studies that are conducted to assess the effect of food on the rate
      and extent of absorption of a drug, either compared to a fasted state or to
      a reference drug.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Food Effect Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Immunogenicity Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C120842
    :notation: IMMUNOGENICITY
    :definition: A study that assesses an agent's ability to provoke an immune response.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Immunogenicity Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Pharmacodynamic Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49662
    :notation: PHARMACODYNAMIC
    :definition: A study of the biochemical and physiological effect of a drug and
      the mechanism of drug action and the relationship between drug concentration
      and effect. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Pharmacodynamic Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Pharmacoeconomic Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C39493
    :notation: PHARMACOECONOMIC
    :definition: A study that assesses the value associated with a given drug in therapeutic
      and economic terms. This type of study is multidisciplinary in nature and takes
      into consideration the social and economic costs (resource utilization costs
      including direct, indirect, and intangible costs) of drug therapy in addition
      to its direct therapeutic benefits. Analyses relate the difference in therapeutic
      benefits to the difference in costs between treatment alternatives. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Pharmacoeconomic Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Pharmacogenetic Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C129001
    :notation: PHARMACOGENETIC
    :definition: A study that assesses variation in DNA sequence, usually within a
      single gene, and its effect on drug response.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Pharmacogenetic Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Pharmacogenomic Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49661
    :notation: PHARMACOGENOMIC
    :definition: A study that identifies or assesses variations within the entire
      genome, including DNA, RNA, or transcriptional elements, and its effects on
      drug response.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Pharmacogenomic Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Pharmacokinetic Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49663
    :notation: PHARMACOKINETIC
    :definition: A study of the process by which a drug is absorbed, distributed,
      metabolized, and eliminated by the body. (NCI)
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Pharmacokinetic Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Position Effect Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161477
    :notation: POSITION EFFECT
    :definition: A type of study designed to evaluate the effect of body position
      during and/or after administration of the investigational product.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Position Effect Trial
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Prevention Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49657
    :notation: PREVENTION
    :definition: A type of study designed to identify actions necessary to permanently
      eliminate or reduce the long-term risk to human life as a result of a particular
      medication or treatment regimen.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Prevention Study
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Prophylaxis Study
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Safety Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49667
    :notation: SAFETY
    :definition: A study that assesses the medical risks to a subject. Safety is usually
      assessed by examining a wide range of clinical parameters, including adverse
      events, vital signs, physical exam, laboratory tests.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Safety Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Swallowing Function Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161478
    :notation: SWALLOWING FUNCTION
    :definition: A type of study designed to evaluate the effect of the investigational
      product on the physiologic act of swallowing.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Swallowing Function Trial
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Thorough QT Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C158287
    :notation: THOROUGH QT
    :definition: A type of study designed to evaluate the ability of an investigational
      product and/or approved drug to delay cardiac ventricular repolarization as
      detected by QT prolongation and other ECG parameters.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Thorough QT Study
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: TQT Study
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Tolerability Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C98791
    :notation: TOLERABILITY
    :definition: A type of safety study that assesses the degree to which overt adverse
      effects can be tolerated by the subject.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Tolerability Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Treatment Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C49656
    :notation: TREATMENT
    :definition: A type of study designed to evaluate intervention(s) for treatment
      of disease, syndrome or condition.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Treatment Study
      :tagged: []
    :synonym:
    - :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
      :label: Therapy Trial
      :tagged: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Usability Testing Study
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161479
    :notation: USABILITY TESTING
    :definition: A type of study designed to evaluate the user experience with a product.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Usability Testing Study
      :tagged: []
    :synonym: []
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#UnmanagedConcept
    :label: Water Effect Trial
    :tagged:
    - :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvQ1NOI2M1ZTAzOTY0LTg5YWItNGI0OC1iMmRkLWFhN2JhYTEwNmQzOA==
      :uri: http://www.assero.co.uk/CSN#c5e03964-89ab-4b48-b2dd-aa7baa106d38
      :rdf_type: http://www.assero.co.uk/ISO11179Concepts#ConceptSystemNode
      :pref_label: Protocol
      :description: Protocol related information.
      :narrower: []
    :identifier: C161480
    :notation: WATER EFFECT
    :definition: A type of study designed to evaluate the effects of water on investigational
      product safety and/or efficacy.
    :extensible: false
    :narrower: []
    :preferred_term:
      :id: 
      :uri: {}
      :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
      :label: Water Effect Trial
      :tagged: []
    :synonym: []
  :extends: 
  :subsets: 
  :preferred_term:
    :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#PreferredTerm
    :label: CDISC SDTM Trial Type Terminology
    :tagged: []
  :synonym:
  - :id: 
    :uri: {}
    :rdf_type: http://www.assero.co.uk/Thesaurus#Synonym
    :label: Trial Type Response
    :tagged: []
  :is_ordered: 
